购物车
您的购物车当前为空
L524-0366 ([1-(3-chlorophenyl)triazol-4-yl]-thiomorpholino-methanone) 是一种 TWEAK-Fn14 信号级联抑制剂。
别名 [1-(3-chlorophenyl)triazol-4-yl]-thiomorpholino-methanone
L524-0366 ([1-(3-chlorophenyl)triazol-4-yl]-thiomorpholino-methanone) 是一种 TWEAK-Fn14 信号级联抑制剂。

| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,380 | 1-2周 | |
| 5 mg | ¥ 2,980 | 1-2周 | |
| 10 mg | ¥ 4,480 | 1-2周 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
| 产品描述 | L524-0366 ([1-(3-chlorophenyl)triazol-4-yl]-thiomorpholino-methanone) is a TWEAK-Fn14 signaling cascade inhibitor. |
| 靶点活性 | sTWEAK:7.8 µM |
| 体外活性 | L524-0366通过TAC减轻了不良重塑。TWEAK通过部分激活非典型NF-κB信号传导,诱导了来自WT但不是Fn14-/-纤维细胞的促炎症趋化因子,单核细胞趋化蛋白1的分泌。最终,在TAC后的小鼠以及人类衰竭心脏中,发现Fn14表达增加。 |
| 细胞实验 | Wild type (WT) and Fn14 knock out (Fn14-/-) mice were subjected to pressure overload [transaortic constriction (TAC)] for 1 or 6 weeks. A subset of WT TAC animals were treated with the Fn14 antagonist L524-0366. Cardiac function was measured by echocardiography. Cardiac fibrosis and macrophage infiltration were quantified using immunohistochemistry and flow cytometry, respectively. Cardiac fibroblasts were isolated for quantifying TWEAK-induced chemokine release. |
| 别名 | [1-(3-chlorophenyl)triazol-4-yl]-thiomorpholino-methanone |
| 分子量 | 308.79 |
| 分子式 | C13H13ClN4OS |
| CAS No. | 951612-19-4 |
| Smiles | C(=O)(C1=CN(N=N1)C2=CC(Cl)=CC=C2)N3CCSCC3 |
| 密度 | no data available |
| 存储 | Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准 | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 25 mg/mL (80.96 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| 体内实验配方 | 5% DMSO+95% Corn oil: 1 mg/mL (3.24 mM), Suspension. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。 | |||||||||||||||||||||||||||||||
对于不同动物的给药剂量换算,您也可以参考 更多